Hyaluronic Acid Viscosupplementation | Medtech 360 | Market Analysis | Global | 2016
The global market for HA viscosupplementation will exhibit moderate growth through 2024, driven by rising use of this treatment, especially in the Asia Pacific region. While premium-priced single injection products will continue to become more popular over the forecast period, 3- and 5-injection products will retain their dominance in some countries due to differences in product access, reimbursement, and because there is more clinical data supporting the efficacy of these products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the US, Europe, Asia Pacific, and Brazil across a 10-year period.